Advertisement

Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial)

      The objective of this study was to compare outcomes in women after surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR) using a self-expanding prosthesis in patients with severe aortic stenosis who were at high risk for SAVR. Although registries and meta-analyses have suggested that TAVR is of considerable benefit in women, perhaps even more so than in men, a rigorous evaluation of TAVR with a self-expanding valve versus SAVR in women from a randomized trial has not been performed. Patients with severe aortic stenosis were randomized 1:1 to either TAVR or SAVR. Outcomes at 1 year are reported. Treatment was attempted in a total of 353 women (183 TAVR and 170 SAVR). Baseline characteristics and predicted risk of the 2 groups were comparable, although the frequency of diabetes mellitus was lower in patients undergoing TAVR (33.3% vs 45.3%; p = 0.02). TAVR-treated patients experienced a statistically significant 1-year survival advantage compared with SAVR patients (12.7% vs 21.8%; p = 0.03). The composite all-cause mortality or major stroke rate also favored TAVR (14.9% vs 24.2%; p = 0.04). Quality of life, as measured by the Kansas City Cardiomyopathy Questionnaire summary score, for both the TAVR and SAVR groups increased significantly from baseline to 1 year. In conclusion, female TAVR patients had lower 1-year mortality and lower 1-year all-cause mortality or major stroke compared with women undergoing SAVR, with both cohorts experiencing improved quality of life. Further studies specifically in women are warranted to validate these findings.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nishimura R.A.
        • Otto C.M.
        • Bonow R.O.
        • Carabello B.A.
        • Erwin 3rd, J.P.
        • Guyton R.A.
        • O'Gara P.T.
        • Ruiz C.E.
        • Skubas N.J.
        • Sorajja P.
        • Sundt 3rd, T.M.
        • Thomas J.D.
        • Anderson J.L.
        • Halperin J.L.
        • Albert N.M.
        • Bozkurt B.
        • Brindis R.G.
        • Creager M.A.
        • Curtis L.H.
        • DeMets D.
        • Guyton R.A.
        • Hochman J.S.
        • Kovacs R.J.
        • Ohman E.M.
        • Pressler S.J.
        • Sellke F.W.
        • Shen W.K.
        • Stevenson W.G.
        • Yancy C.W.
        • American College of Cardiology, American College of Cardiology/American Heart Association
        • American Heart Association
        2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines.
        J Thorac Cardiovasc Surg. 2014; 148: e1-e132
        • Popma J.J.
        • Adams D.H.
        • Reardon M.J.
        • Yakubov S.J.
        • Kleiman N.S.
        • Heimansohn D.
        • Hermiller Jr., J.
        • Hughes G.C.
        • Harrison J.K.
        • Coselli J.
        • Diez J.
        • Kafi A.
        • Schreiber T.
        • Gleason T.G.
        • Conte J.
        • Buchbinder M.
        • Deeb G.M.
        • Carabello B.
        • Serruys P.W.
        • Chenoweth S.
        • Oh J.K.
        • CoreValve United States Clinical Investigators
        Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
        J Am Coll Cardiol. 2014; 63: 1972-1981
        • Adams D.H.
        • Popma J.J.
        • Reardon M.J.
        • Yakubov S.J.
        • Coselli J.S.
        • Deeb G.M.
        • Gleason T.G.
        • Buchbinder M.
        • Hermiller Jr., J.
        • Kleiman N.S.
        • Chetcuti S.
        • Heiser J.
        • Merhi W.
        • Zorn G.
        • Tadros P.
        • Robinson N.
        • Petrossian G.
        • Hughes G.C.
        • Harrison J.K.
        • Conte J.
        • Maini B.
        • Mumtaz M.
        • Chenoweth S.
        • Oh J.K.
        • US CoreValve Clinical Investigators
        Transcatheter aortic-valve replacement with a self-expanding prosthesis.
        N Engl J Med. 2014; 370: 1790-1798
        • Stangl V.
        • Baldenhofer G.
        • Knebel F.
        • Zhang K.
        • Sanad W.
        • Spethmann S.
        • Grubitzsch H.
        • Sander M.
        • Wernecke K.D.
        • Baumann G.
        • Stangl K.
        • Laule M.
        Impact of gender on three-month outcome and left ventricular remodeling after transfemoral transcatheter aortic valve implantation.
        Am J Cardiol. 2012; 110: 884-890
        • Humphries K.H.
        • Toggweiler S.
        • Rodes-Cabau J.
        • Nombela-Franco L.
        • Dumont E.
        • Wood D.A.
        • Willson A.B.
        • Binder R.K.
        • Freeman M.
        • Lee M.K.
        • Gao M.
        • Izadnegahdar M.
        • Ye J.
        • Cheung A.
        • Webb J.G.
        Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis.
        J Am Coll Cardiol. 2012; 60: 882-886
        • Conrotto F.
        • D'Ascenzo F.
        • Presbitero P.
        • Humphries K.H.
        • Webb J.G.
        • O'Connor S.A.
        • Morice M.C.
        • Lefevre T.
        • Grasso C.
        • Sbarra P.
        • Taha S.
        • Omede P.
        • Grosso Marra W.
        • Salizzoni S.
        • Moretti C.
        • D'Amico M.
        • Biondi-Zoccai G.
        • Gaita F.
        • Marra S.
        Effect of gender after transcatheter aortic valve implantation: a meta-analysis.
        Ann Thorac Surg. 2015; 99: 809-816
        • Stangl V.
        • Baldenhofer G.
        • Laule M.
        • Baumann G.
        • Stangl K.
        Influence of sex on outcome following transcatheter aortic valve implantation (TAVI): systematic review and meta-analysis.
        J Interv Cardiol. 2014; 27: 531-539
        • Sherif M.A.
        • Zahn R.
        • Gerckens U.
        • Sievert H.
        • Eggebrecht H.
        • Hambrecht R.
        • Sack S.
        • Richardt G.
        • Schneider S.
        • Senges J.
        • Brachmann J.
        Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry.
        Clin Res Cardiol. 2014; 103: 613-620
        • Holmes Jr., D.R.
        • Brennan J.M.
        • Rumsfeld J.S.
        • Dai D.
        • O'Brien S.M.
        • Vemulapalli S.
        • Edwards F.H.
        • Carroll J.
        • Shahian D.
        • Grover F.
        • Tuzcu E.M.
        • Peterson E.D.
        • Brindis R.G.
        • Mack M.J.
        Clinical outcomes at 1 year following transcatheter aortic valve replacement.
        JAMA. 2015; 313: 1019-1028
        • Morice M.C.
        • Mikhail G.W.
        • Mauri i Ferre F.
        • Modena M.G.
        • Strasser R.H.
        • Grinfeld L.
        • Sudhir K.
        • Stuteville M.
        • Papeleu P.
        • Li D.
        • Rutledge D.
        • Windecker S.
        SPIRIT women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes.
        EuroIntervention. 2012; 8: 325-335
        • Mikhail G.W.
        • Gerber R.T.
        • Cox D.A.
        • Ellis S.G.
        • Lasala J.M.
        • Ormiston J.A.
        • Stone G.W.
        • Turco M.A.
        • Joshi A.A.
        • Baim D.S.
        • Colombo A.
        Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the “TAXUS Woman” analysis.
        JACC Cardiovasc Interv. 2010; 3: 1250-1259
        • Al-Alao B.S.
        • Parissis H.
        • McGovern E.
        • Tolan M.
        • Young V.K.
        Gender influence in isolated coronary artery bypass graft surgery: a propensity match score analysis of early outcomes.
        Gen Thorac Cardiovasc Surg. 2012; 60: 417-424
        • Lehmkuhl E.
        • Kendel F.
        • Gelbrich G.
        • Dunkel A.
        • Oertelt-Prigione S.
        • Babitsch B.
        • Knosalla C.
        • Bairey-Merz N.
        • Hetzer R.
        • Regitz-Zagrosek V.
        Gender-specific predictors of early mortality after coronary artery bypass graft surgery.
        Clin Res Cardiol. 2012; 101: 745-751
        • Higgins J.
        • Jamieson W.R.
        • Benhameid O.
        • Ye J.
        • Cheung A.
        • Skarsgard P.
        • Germann E.
        • Chan F.
        • Lichtenstein S.V.
        Influence of patient gender on mortality after aortic valve replacement for aortic stenosis.
        J Thorac Cardiovasc Surg. 2011; 142: 595-601
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.
        • Mehran R.
        • Miller C.
        • Morel M.A.
        • Petersen J.
        • Popma J.J.
        • Takkenberg J.J.
        • Vahanian A.
        • van Es G.A.
        • Vranckx P.
        • Webb J.G.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        Eur Heart J. 2011; 32: 205-217
        • Bohannon R.W.
        • Bear-Lehman J.
        • Desrosiers J.
        • Massy-Westropp N.
        • Mathiowetz V.
        Average grip strength: a meta-analysis of data obtained with a Jamar dynamometer from individuals 75 years or more of age.
        J Geriatr Phys Ther. 2007; 30: 28-30
        • Bosmans J.
        • Bleiziffer S.
        • Gerckens U.
        • Wenaweser P.
        • Brecker S.
        • Tamburino C.
        • Linke A.
        • Advance Study Investigators
        The incidence and predictors of early- and mid-term clinically relevant neurological events after transcatheter aortic valve replacement in real-world patients.
        J Am Coll Cardiol. 2015; 66: 209-217
        • O'Brien S.M.
        • Shahian D.M.
        • Filardo G.
        • Ferraris V.A.
        • Haan C.K.
        • Rich J.B.
        • Normand S.L.
        • DeLong E.R.
        • Shewan C.M.
        • Dokholyan R.S.
        • Peterson E.D.
        • Edwards F.H.
        • Anderson R.P.
        • Society of Thoracic Surgeons Quality Measurement Task Force
        The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2−isolated valve surgery.
        Ann Thorac Surg. 2009; 88: S23-S42
        • Williams M.
        • Kodali S.K.
        • Hahn R.T.
        • Humphries K.H.
        • Nkomo V.T.
        • Cohen D.J.
        • Douglas P.S.
        • Mack M.
        • McAndrew T.C.
        • Svensson L.
        • Thourani V.H.
        • Tuzcu E.M.
        • Weissman N.J.
        • Kirtane A.J.
        • Leon M.B.
        Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
        J Am Coll Cardiol. 2014; 63: 1522-1528
        • Hayashida K.
        • Morice M.C.
        • Chevalier B.
        • Hovasse T.
        • Romano M.
        • Garot P.
        • Farge A.
        • Donzeau-Gouge P.
        • Bouvier E.
        • Cormier B.
        • Lefevre T.
        Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis.
        J Am Coll Cardiol. 2012; 59: 566-571
        • Nguyen T.C.
        • Babaliaros V.C.
        • Razavi S.A.
        • Kilgo P.D.
        • Guyton R.A.
        • Devireddy C.M.
        • Shults C.C.
        • Mavromatis K.
        • Kanitkar M.
        • Block P.
        • Lerakis S.
        • Thourani V.H.
        Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
        J Thorac Cardiovasc Surg. 2013; 146 (discussion 13406–13407): 1399-1406
        • Thourani V.H.
        • Keeling W.B.
        • Sarin E.L.
        • Guyton R.A.
        • Kilgo P.D.
        • Dara A.B.
        • Puskas J.D.
        • Chen E.P.
        • Cooper W.A.
        • Vega J.D.
        • Morris C.D.
        • Halkos M.E.
        • Lattouf O.M.
        Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement.
        Ann Thorac Surg. 2011; 91 (discussion 1806–1807): 1798-1806
        • Mitter N.
        • Shah A.
        • Yuh D.
        • Dodd O.J.
        • Thompson R.E.
        • Cameron D.
        • Hogue C.W.
        Renal injury is associated with operative mortality after cardiac surgery for women and men.
        J Thorac Cardiovasc Surg. 2010; 140: 1367-1373
        • Webb J.G.
        • Altwegg L.
        • Boone R.H.
        • Cheung A.
        • Ye J.
        • Lichtenstein S.
        • Lee M.
        • Masson J.B.
        • Thompson C.
        • Moss R.
        • Carere R.
        • Munt B.
        • Nietlispach F.
        • Humphries K.
        Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes.
        Circulation. 2009; 119: 3009-3016
        • Brown J.R.
        • Cochran R.P.
        • Dacey L.J.
        • Ross C.S.
        • Kunzelman K.S.
        • Dunton R.F.
        • Braxton J.H.
        • Charlesworth D.C.
        • Clough R.A.
        • Helm R.E.
        • Leavitt B.J.
        • Mackenzie T.A.
        • O'Connor G.T.
        • Northern New England Cardiovascular Disease Study Group
        Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery.
        Circulation. 2006; 114: I409-I413
        • Hobson C.E.
        • Yavas S.
        • Segal M.S.
        • Schold J.D.
        • Tribble C.G.
        • Layon A.J.
        • Bihorac A.
        Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.
        Circulation. 2009; 119: 2444-2453
        • Borz B.
        • Durand E.
        • Godin M.
        • Tron C.
        • Canville A.
        • Litzler P.Y.
        • Bessou J.P.
        • Cribier A.
        • Eltchaninoff H.
        Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
        Heart. 2013; 99: 860-865
        • Pilgrim T.
        • Stortecky S.
        • Luterbacher F.
        • Windecker S.
        • Wenaweser P.
        Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis.
        J Thromb Thrombolysis. 2013; 35: 456-462